Rodman & Renshaw Downgrades BioSante Pharmaceuticals (BPAX) to Market Perform
Tweet
Share
E-mailGet Alerts BPAX Hot Sheet
Price: $1.09 --0%
Rating Summary:
0 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
0 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Rodman & Renshaw downgraded BioSante Pharmaceuticals (NASDAQ: BPAX) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on BioSante Pharmaceuticals click here. For more ratings news on BioSante Pharmaceuticals click here.
Shares of BioSante Pharmaceuticals closed at $2.12 yesterday.
For an analyst ratings summary and ratings history on BioSante Pharmaceuticals click here. For more ratings news on BioSante Pharmaceuticals click here.
Shares of BioSante Pharmaceuticals closed at $2.12 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- Desjardins Downgrades Alithya Group Inc. (ALYA:CN) (ALYA) to Hold
- Northcoast Downgrades Brinker Int'l (EAT) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Rodman & RenshawSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
